Roche granted FDA Breakthrough Device Designation
Supporting earlier Alzheimer's disease diagnosis
Stay updated with breaking news from Roche Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Supporting earlier Alzheimer's disease diagnosis
Prenosis, which is based in Chicago, has announced that it will work with Roche Diagnostics to bring its Sepsis ImmunoScore tool to hospitals across the country.
Using nearly 1.5 million health records from >350,000 older adults with diabetes in Hong Kong, Elaine Chow and colleagues investigate a novel machine learning model to predict risk of severe hypoglycaemia.
The Elecsys® pTau217 plasma biomarker test is being developed as part of an ongoing partnership between Roche and Eli Lilly and CompanyOnce approved, the test will aid healthcare providers in...
CG Life acquires digital agency Toolhouse. From PR Week